Found 197 matching trials
Trifluridine/tipiracil (TAS-102), Bevacizumab, and Camrelizumab As Third-line or Later-line Therapy of Gastric Cancer PHASE2 For patients with metastatic gastric cancer, the efficacy of current standa...
Show More Location
Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial
Evaluation of Efficacy of Trifluridine/Tipiracil Plus an Anti-IL-1α True Human Antibody Versus Trifluridine/Tipiracil Plus Placebo in Metastatic Colorectal Cancer Patients After Failure of Oxaliplatin, Irinotecan, Fluoropyrimidine PHASE1 Unresectable metastatic colorectal cancer (mCRC) remains an incurable disea...
Show More Status
Active Not Recruiting
Location
Centre Georges-François Leclerc
Learn More & Join Trial
Trifluridine/Tipiracil Plus Regorafenib vs Trifluridine/Tipiracil Plus Bevacizumab for Refractory Metastatic Colorectal Cancer PHASE3 The goal of this clinical trial is to demonstrate the non-inferiority of tr...
Show More Location
The Second Affiliated Hospital, Zhejiang University School of Medicine
Learn More & Join Trial
Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies PHASE3 The purpose of this study is to compare the efficacy and safety of TAS-102 ...
Show More Location
Arizona Center for Cancer Care
Learn More & Join Trial
Trifluridine/Tipiracil Combined With Oxaliplatin and Bevacizumab Versus XELOX Plus Bevacizumab in mCRC PHASE2 This is a two-group, parallel, randomized, standard-control phase II study ...
Show More Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
Investigate the Efficacy of Chemotherapy in Patients With Positive ctDNA After Surgery and Adjuvant Chemotherapy for a Stage III Colorectal Cancer PHASE3 Phase III multicentric, open-label, randomized study
The main objective is...
Show More Location
Chu Dijon Bourgogne
Learn More & Join Trial
Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver Metastases PHASE1 This is a phase I dose escalation study (3+3 design) with a dose expansion ...
Show More Location
University of California San Francisco
Learn More & Join Trial
A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015) PHASE3 This study will compare how safe and effective sacituzumab tirumotecan is v...
Show More Status
Active Not Recruiting
Location
Banner MD Anderson Cancer Center ( Site 0119)
Learn More & Join Trial
A Study to Assess the Safety, Pharmacokinetics and Anti Tumor Activity of UCB6114 Administered Intravenously to Participants With Advanced Solid Tumors PHASE1 The purpose of the study is to characterize the safety and pharmacokinetic ...
Show More Learn More & Join Trial
ctDNA-Guided Cetuximab or Bevacizumab Plus Trifluridine/Tipiracil in RAS/BRAF Wild-Type mCRC PHASE1 The objective of this randomized controlled clinical trial is to evaluate t...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial